(2002; 166 pages)
1. Governments should acknowledge the problem of counterfeit drugs by developing national policies and providing a comprehensive legal framework to regulate trading of counterfeit drugs as a criminal offence.
2. Governments should adopt WHO guidelines for the development of measures to combat counterfeit drugs.
3. Governments of exporting countries should have a system of control to prevent the export of counterfeit drugs.
4. Drug regulatory authorities should establish a working relationship with national (police, customs) and international (Interpol, World Customs Organization) law enforcement agencies.
5. Drug regulatory authorities should establish an effective registration system to include the licensing of manufacturers, wholesalers, and retail outlets.
6. Drug regulatory authorities should seek to cooperate with the drug industry in the exchange of information on counterfeit drugs, and to promote reporting of counterfeit drugs to WHO.
7. WHO should strengthen the existing anti-counterfeit liaison officers to promote exchange of information on counterfeit drugs amongst and between regulatory authorities and WHO.
8. WHO should encourage and support Member States to develop and implement national measures for combating counterfeit drugs.
9. WHO should organize meetings to enhance international communication on counterfeit problems and encourage and assist regulatory authorities in the delivery of public awareness programmes on the dangers of counterfeit drugs.
10. Progress should be reported back to the ICDRA.